Generate a tailored SOP for Dr. Edna Hardeman. Improve your application with a focused, well-structured draft.
Professor Edna Hardeman, currently at the University of New South Wales, has built an international reputation in the field of muscle gene regulation and gene therapies for muscle diseases. After completing her BA/BSc at the University of Texas at Austin, she earned her PhD in Biological Sciences from Stanford University, focusing on cholesterol biosynthesis. Following her doctoral studies, she undertook a postdoctoral fellowship in the Department of Pharmacology at Stanford Medical School, where she investigated muscle determination factors. In 2009, she moved to UNSW to establish the Cellular and Genetic Medicine Unit and became the Head of Cell Biology in 2018. Her research has explored the role of actin and tropomyosin in cellular functions and their relevance in cancer therapy, demonstrating the potential of tropomyosin as a drug target in neuroblastoma treatment. Professor Hardeman has served in various leadership roles, including chairing the NHMRC Animal Welfare Committee and actively contributing to academic boards. She has led significant research projects funded by prominent agencies, including grants focusing on membrane dynamics and tropomyosin targeting in human diseases.
University of New South Wales • Sydney, NSW, Australia
Leader of the Cell Biology department, overseeing research in muscle gene regulation and drug development.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.